The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Moser, J., Kool, H., Giakzidis, I., Caldecott, K., Mullenders, L. H. F., & Fousteri, M. I. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.014 · Cited by 261
RetractedComprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
Döhner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M., & Lichter, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432602 · Cited by 3,318
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway
Lieber, M. R. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.093131 · Cited by 2,882
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Hoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
The DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705
Mechanism of Eukaryotic Homologous Recombination
San Filippo, J., Sung, P., & Klein, H. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061306.125255 · Cited by 1,681
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671
The DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,649
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
Chapman, J. R., Taylor, M. R. G., & Boulton, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.029 · Cited by 1,625
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramis, G., Jares, P., Beà, S., González-Díaz, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,514
Mechanisms and functions of DNA mismatch repair
Li, G.-M. (2008) · Cell Research · doi:10.1038/cr.2007.115 · Cited by 1,487
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
Emerging landscape of oncogenic signatures across human cancers
Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013) · Nature Genetics · doi:10.1038/ng.2762 · Cited by 1,378
The multifaceted mismatch-repair system
Jiricny, J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1907 · Cited by 1,370
Kunkel, T. A., & Erie, D. A. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133243 · Cited by 1,367
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Schlacher, K., Christ, N., Siaud, N., Egashira, A., Wu, H., & Jasin, M. (2011) · Cell · doi:10.1016/j.cell.2011.03.041 · Cited by 1,255
Base-excision repair of oxidative DNA damage
David, S. S., O'Shea, V. L., & Kundu, S. (2007) · Nature · doi:10.1038/nature05978 · Cited by 1,238
Homologous recombination in DNA repair and DNA damage tolerance
Li, X., & Heyer, W.-D. (2008) · Cell Research · doi:10.1038/cr.2008.1 · Cited by 1,197
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Sakai, W., Swisher, E. M., Karlan, B. Y., Agarwal, M. K., Higgins, J., Friedman, C., Villegas, E., Jacquemont, C., Farrugia, D. J., Couch, F. J., et al. (2008) · Nature · doi:10.1038/nature06633 · Cited by 1,086
Regulation of Homologous Recombination in Eukaryotes
Heyer, W.-D., Ehmsen, K. T., & Liu, J. (2010) · Annual Review of Genetics · doi:10.1146/annurev-genet-051710-150955 · Cited by 1,066
Resistance to therapy caused by intragenic deletion in BRCA2
Edwards, S. L., Brough, R., Lord, C. J., Natrajan, R., Vatcheva, R., Levine, D. A., Boyd, J., Reis-Filho, J. S., & Ashworth, A. (2008) · Nature · doi:10.1038/nature06548 · Cited by 1,011
Bouwman, P., Aly, A., Escandell, J. M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1831 · Cited by 1,001
EUKARYOTIC TRANSLESION SYNTHESIS DNA POLYMERASES: Specificity of Structure and Function
Prakash, S., Johnson, R. E., & Prakash, L. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133250 · Cited by 1,000
Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 996
MMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endings
McVey, M., & Lee, S. E. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.08.007 · Cited by 986
Rottenberg, S., Jaspers, J. E., Kersbergen, A., van der Burg, E., Nygren, A. O. H., Zander, S. A. L., Derksen, P. W. B., de Bruin, M., Zevenhoven, J., Lau, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806092105 · Cited by 956
Schlacher, K., Wu, H., & Jasin, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.015 · Cited by 936
Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis
Moynahan, M. E., & Jasin, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2851 · Cited by 930
Masson, M., Niedergang, C., Schreiber, V., Muller, S., Menissier-de Murcia, J., & de Murcia, G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3563 · Cited by 910
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 904
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Helleday, T. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.001 · Cited by 856
Xu, Y., Ashley, T., Brainerd, E. E., Bronson, R. T., Meyn, M. S., & Baltimore, D. (1996) · Genes & Development · doi:10.1101/gad.10.19.2411 · Cited by 827
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Wang, M., Wu, W., Wu, W., Rosidi, B., Zhang, L., Wang, H., & Iliakis, G. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl840 · Cited by 820
MGMT: its role in cancer aetiology and cancer therapeutics
Gerson, S. L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1319 · Cited by 813
Weinstein, I. B., & Joe, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3293 · Cited by 805
Zur Frage der Entstehung maligner Tumoren
Boveri, T. (1914) · Cited by 801
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Weller, M., Stupp, R., Reifenberger, G., Brandes, A. A., van den Bent, M. J., Wick, W., & Hegi, M. E. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.197 · Cited by 778
Loeb, L. A., Loeb, K. R., & Anderson, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0334858100 · Cited by 762
Meindl, A., Hellebrand, H., Wiek, C., Erven, V., Wappenschmidt, B., Niederacher, D., Freund, M., Lichtner, P., Hartmann, L., Schaal, H., et al. (2010) · Nature Genetics · doi:10.1038/ng.569 · Cited by 743
How nucleotide excision repair protects against cancer
Friedberg, E. C. (2001) · Nature Reviews Cancer · doi:10.1038/35094000 · Cited by 730
Audebert, M., Salles, B., & Calsou, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404524200 · Cited by 707
Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy
Weinstein, I. B., & Joe, A. K. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0558 · Cited by 705
Mechanism of homologous recombination: mediators and helicases take on regulatory functions
Sung, P., & Klein, H. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2008 · Cited by 700
DNA repair mechanisms in dividing and non-dividing cells
Iyama, T., & Wilson, D. M. (2013) · DNA Repair · doi:10.1016/j.dnarep.2013.04.015 · Cited by 697
Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells
Hegde, M. L., Hazra, T. K., & Mitra, S. (2008) · Cell Research · doi:10.1038/cr.2008.8 · Cited by 661
El-Khamisy, S. F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg761 · Cited by 659
Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC
Jain, M., Arvanitis, C., Chu, K., Dewey, W., Leonhardt, E., Trinh, M., Sundberg, C. D., Bishop, J. M., & Felsher, D. W. (2002) · Science · doi:10.1126/science.1071489 · Cited by 644
Homologous recombination and its regulation
Krejci, L., Altmannova, V., Spirek, M., & Zhao, X. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks270 · Cited by 641
Endonucleolytic Function of MutLα in Human Mismatch Repair
Kadyrov, F. A., Dzantiev, L., Constantin, N., & Modrich, P. (2006) · Cell · doi:10.1016/j.cell.2006.05.039 · Cited by 626
Fanconi anaemia and the repair of Watson and Crick DNA crosslinks
Kottemann, M. C., & Smogorzewska, A. (2013) · Nature · doi:10.1038/nature11863 · Cited by 611
PARP is activated at stalled forks to mediate Mre11‐dependent replication restart and recombination
Bryant, H. E., Petermann, E., Schultz, N., Jemth, A., Loseva, O., Issaeva, N., Johansson, F., Fernandez, S., McGlynn, P., & Helleday, T. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.206 · Cited by 602
Repair of O6-alkylguanine by alkyltransferases
Pegg, A. E. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00017-x · Cited by 576
Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis
Hashimoto, Y., Ray Chaudhuri, A., Lopes, M., & Costanzo, V. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1927 · Cited by 548
The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases
McCulloch, S. D., & Kunkel, T. A. (2008) · Cell Research · doi:10.1038/cr.2008.4 · Cited by 544
Patel, A. G., Sarkaria, J. N., & Kaufmann, S. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013715108 · Cited by 541
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
Kim, H., & D'Andrea, A. D. (2012) · Genes & Development · doi:10.1101/gad.195248.112 · Cited by 508
The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
De Vos, M., Schreiber, V., & Dantzer, F. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.03.018 · Cited by 492
Fousteri, M., & Mullenders, L. H. (2008) · Cell Research · doi:10.1038/cr.2008.6 · Cited by 487
Reversible Activation of c-Myc in Skin
Pelengaris, S., Littlewood, T., Khan, M., Elia, G., & Evan, G. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80350-0 · Cited by 468
The p53 network: cellular and systemic DNA damage responses in aging and Cancer
Reinhardt, H. C., & Schumacher, B. (2012) · Trends in Genetics · doi:10.1016/j.tig.2011.12.002 · Cited by 458
Self-citationModernizing the Nonhomologous End-Joining Repertoire: Alternative and Classical NHEJ Share the Stage
Deriano, L., & Roth, D. B. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155540 · Cited by 453
Almeida, K. H., & Sobol, R. W. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.01.009 · Cited by 437
A Targeted DNA-PKcs-Null Mutation Reveals DNA-PK-Independent Functions for KU in V(D)J Recombination
Gao, Y., Chaudhuri, J., Zhu, C., Davidson, L., Weaver, D. T., & Alt, F. W. (1998) · Immunity · doi:10.1016/s1074-7613(00)80619-6 · Cited by 432
Cancer in xeroderma pigmentosum and related disorders of DNA repair
Cleaver, J. E. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1652 · Cited by 427
Isolation of ORC6 , a Component of the Yeast Origin Recognition Complex by a One-Hybrid System
Li, J. J., & Herskowitz, I. (1993) · Science · doi:10.1126/science.8266075 · Cited by 424
The endless tale of non-homologous end-joining
Weterings, E., & Chen, D. J. (2008) · Cell Research · doi:10.1038/cr.2008.3 · Cited by 418
Ogi, T., Limsirichaikul, S., Overmeer, R. M., Volker, M., Takenaka, K., Cloney, R., Nakazawa, Y., Niimi, A., Miki, Y., Jaspers, N. G., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.009 · Cited by 392
Ivanov, E. L., Sugawara, N., Fishman-Lobell, J., & Haber, J. E. (1996) · Genetics · doi:10.1093/genetics/142.3.693 · Cited by 390
Repair of Double-Strand Breaks by End Joining
Chiruvella, K. K., Liang, Z., & Wilson, T. E. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012757 · Cited by 376
Repair of DNA double strand breaks by non-homologous end joining
Lees-Miller, S. (2003) · Biochimie · doi:10.1016/j.biochi.2003.10.011 · Cited by 366
Mechanisms of double-strand break repair in somatic mammalian cells
Hartlerode, A. J., & Scully, R. (2009) · Biochemical Journal · doi:10.1042/bj20090942 · Cited by 365
Structure of the Human MutSα DNA Lesion Recognition Complex
Warren, J. J., Pohlhaus, T. J., Changela, A., Iyer, R. R., Modrich, P. L., & Beese, L. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.018 · Cited by 362
Srivastava, M., Nambiar, M., Sharma, S., Karki, S. S., Goldsmith, G., Hegde, M., Kumar, S., Pandey, M., Singh, R. K., Ray, P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.054 · Cited by 355
Gastrulation in the mouse : Growth and regionalization of the epiblast
Snow, M. H. L. (1977) · Development · doi:10.1242/dev.42.1.293 · Cited by 351
53BP1 Mediates Productive and Mutagenic DNA Repair through Distinct Phosphoprotein Interactions
Callen, E., Di Virgilio, M., Kruhlak, M. J., Nieto-Soler, M., Wong, N., Chen, H.-T., Faryabi, R. B., Polato, F., Santos, M., Starnes, L. M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.023 · Cited by 346
Zur Frage der Entstehung maligner Tumoren
Ribbert, H., & Bally, W. (1914) · Die Naturwissenschaften · doi:10.1007/bf01497322 · Cited by 340
Translating cancer research into targeted therapeutics
de Bono, J. S., & Ashworth, A. (2010) · Nature · doi:10.1038/nature09339 · Cited by 335
Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
Evers, B., Drost, R., Schut, E., de Bruin, M., van der Burg, E., Derksen, P. W. B., Holstege, H., Liu, X., van Drunen, E., Beverloo, H. B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4953 · Cited by 335
Sugawara, N., Pâques, F., Colaiácovo, M., & Haber, J. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9214 · Cited by 317
Cao, L., Xu, X., Bunting, S. F., Liu, J., Wang, R.-H., Cao, L. L., Wu, J. J., Peng, T.-N., Chen, J., Nussenzweig, A., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.037 · Cited by 309
Strom, C. E., Johansson, F., Uhlen, M., Szigyarto, C. A.-K., Erixon, K., & Helleday, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1241 · Cited by 296
Targeted therapy for cancer using PARP inhibitors
Lord, C. J., & Ashworth, A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.016 · Cited by 289
PCNA on the crossroad of cancer
Stoimenov, I., & Helleday, T. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370605 · Cited by 289
Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology
Shuck, S. C., Short, E. A., & Turchi, J. J. (2008) · Cell Research · doi:10.1038/cr.2008.2 · Cited by 281
Sugawara, N., Ira, G., & Haber, J. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5300-5309.2000 · Cited by 277
Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response
Reinhardt, H. C., & Yaffe, M. B. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3640 · Cited by 266
Self-citationPCNA function in the activation and strand direction of MutLα endonuclease in mismatch repair
Pluciennik, A., Dzantiev, L., Iyer, R. R., Constantin, N., Kadyrov, F. A., & Modrich, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010662107 · Cited by 265
Double strand break repair functions of histone H2AX
Scully, R., & Xie, A. (2013) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2013.07.007 · Cited by 252
BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair
Bunting, S. F., Callén, E., Kozak, M. L., Kim, J. M., Wong, N., López-Contreras, A. J., Ludwig, T., Baer, R., Faryabi, R. B., Malhowski, A., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.02.015 · Cited by 252
hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci
Kleczkowska, H. E., Marra, G., Lettieri, T., & Jiricny, J. (2001) · Genes & Development · doi:10.1101/gad.191201 · Cited by 250
Austen, B., Skowronska, A., Baker, C., Powell, J. E., Gardiner, A., Oscier, D., Majid, A., Dyer, M., Siebert, R., Taylor, A. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2649 · Cited by 248
Cancers Exhibit a Mutator Phenotype: Clinical Implications
Loeb, L. A., Bielas, J. H., & Beckman, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5835 · Cited by 221
Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development
Heyer, B. S., MacAuley, A., Behrendtsen, O., & Werb, Z. (2000) · Genes & Development · doi:10.1101/gad.14.16.2072 · Cited by 210
Eukaryotic DNA damage tolerance and translesion synthesis through covalent modifications of PCNA
Andersen, P. L., Xu, F., & Xiao, W. (2008) · Cell Research · doi:10.1038/cr.2007.114 · Cited by 204
Tracing the network connecting brca and fanconi anaemia proteins
Venkitaraman, A. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1321 · Cited by 200
Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair
Risinger, J. I., Umar, A., Boyd, J., Berchuck, A., Kunkel, T. A., & Barrett, J. C. (1996) · Nature Genetics · doi:10.1038/ng0996-102 · Cited by 176
The scaffold protein Ste5 directly controls a switch-like mating decision in yeast
Malleshaiah, M. K., Shahrezaei, V., Swain, P. S., & Michnick, S. W. (2010) · Nature · doi:10.1038/nature08946 · Cited by 175
Mechanism of mismatch recognition revealed by human MutSβ bound to unpaired DNA loops
Gupta, S., Gellert, M., & Yang, W. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2175 · Cited by 173
Alternative end-joining pathway(s): Bricolage at DNA breaks
Frit, P., Barboule, N., Yuan, Y., Gomez, D., & Calsou, P. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.02.007 · Cited by 167
Familial pancreatic cancer—current knowledge
Bartsch, D. K., Gress, T. M., & Langer, P. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.111 · Cited by 164
Non-homologous end-joining, a sticky affair
van Gent, D. C., & van der Burg, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210871 · Cited by 163
Repair of DNA loops involves DNA-mismatch and nucleotide-excision repair proteins
Kirkpatrick, D. T., & Petes, T. D. (1997) · Nature · doi:10.1038/43225 · Cited by 163
Establishing Genetic Interactions by a Synthetic Dosage Lethality Phenotype
Kroll, E. S., Hyland, K. M., Hieter, P., & Li, J. J. (1996) · Genetics · doi:10.1093/genetics/143.1.95 · Cited by 162
BRCA mutations in the management of breast cancer: the state of the art
Narod, S. A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.166 · Cited by 161
Genetic Instability Caused by Loss of MutS Homologue 3 in Human Colorectal Cancer
Haugen, A. C., Goel, A., Yamada, K., Marra, G., Nguyen, T.-P., Nagasaka, T., Kanazawa, S., Koike, J., Kikuchi, Y., Zhong, X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0002 · Cited by 154
Guerrette, S., Wilson, T., Gradia, S., & Fishel, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6616 · Cited by 150
Saparbaev, M. K., Prakash, L., & Prakash, S. (1996) · Genetics · doi:10.1093/genetics/142.3.727 · Cited by 145
Synthetic lethality between mutation in Atm and DNA-PK cs during murine embryogenesis
Gurley, K. E., & Kemp, C. J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00048-3 · Cited by 142
Campalans, A., Kortulewski, T., Amouroux, R., Menoni, H., Vermeulen, W., & Radicella, J. P. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt025 · Cited by 127
Exploiting synthetic lethal interactions for targeted cancer therapy
Reinhardt, H. C., Jiang, H., Hemann, M. T., & Yaffe, M. B. (2009) · Cell Cycle · doi:10.4161/cc.8.19.9626 · Cited by 124
Self-citationInvolvement of Nucleotide Excision and Mismatch Repair Mechanisms in Double Strand Break Repair
Zhang, Y., Rohde, L. H., & Wu, H. (2009) · Current Genomics · doi:10.2174/138920209788488544 · Cited by 122
“Oncogenic Shock”: Explaining Oncogene Addiction through Differential Signal Attenuation
Sharma, S. V., Fischbach, M. A., Haber, D. A., & Settleman, J. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0096 · Cited by 117
Skowrońska, A., Parker, A. E., Ahmed, G., Oldreive, C., Davis, Z. A., Richards, S. M., Dyer, M. J. S., Matutes, E., Gonzalez, D., Taylor, A. M. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0852 · Cited by 117
Lorenzo, S. B. D., Patel, A. G., Hurley, R. M., & Kaufmann, S. H. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00228 · Cited by 117
Searching for synthetic lethality in cancer
Brough, R., Frankum, J. R., Costa-Cabral, S., Lord, C. J., & Ashworth, A. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.009 · Cited by 107
Therapeutic Targeting of a Robust Non-Oncogene Addiction to PRKDC in ATM -Defective Tumors
Riabinska, A., Daheim, M., Herter-Sprie, G. S., Winkler, J., Fritz, C., Hallek, M. J., Thomas, R. K., Kreuzer, K., Frenzel, L. P., Monfared, P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005814 · Cited by 106
Self-citationRole of BRCA1 and BRCA2 mutations in pancreatic cancer
Greer, J. B., & Whitcomb, D. C. (2006) · Gut · doi:10.1136/gut.2006.101220 · Cited by 101
A tale of tails: insights into the coordination of 3′ end processing during homologous recombination
Lyndaker, A. M., & Alani, E. (2009) · BioEssays · doi:10.1002/bies.200800195 · Cited by 94
Evans, E., Sugawara, N., Haber, J. E., & Alani, E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80319-6 · Cited by 94
Surtees, J. A., & Alani, E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.05.032 · Cited by 84
Takahashi, M., Koi, M., Balaguer, F., Boland, C. R., & Goel, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.198804 · Cited by 84
'BRCAness' and its implications for platinum action in gynecologic cancer.
Muggia, F. M., & Safra, T. (2014) · PubMed · Cited by 78
Dietlein, F., Thelen, L., Jokić, M., Jachimowicz, R. D., Ivan, L., Knittel, G., Leeser, U., van Oers, J., Edelmann, W., Heukamp, L. C., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0907 · Cited by 72
Self-citationGermline BRCA1 mutations predispose to pancreatic adenocarcinoma
Al-Sukhni, W., Rothenmund, H., Borgida, A., Zogopoulos, G., O’Shea, A.-M., Pollett, A. F., & Gallinger, S. (2008) · Human Genetics · doi:10.1007/s00439-008-0554-0 · Cited by 67
Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia
Ripollés, L., Ortega, M., Ortuño, F. J., González, A. M., Losada, J., Ojanguren, J., Soler, A., Bergua, J., Coll, M. D., & Caballín, M. R. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.07.006 · Cited by 63
ATM gene deletion in patients with adult acute lymphoblastic leukemia
Haidar, M. A., Kantarjian, H. M., Manshouri, T., Chang, C.-Y., O'Brien, S. M., Freireich, E. J., Keating, M. J., & Albitar, M. X. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1057::aid-cncr16>3.0.co;2-6 · Cited by 56
van Oers, J. M. M., Edwards, Y. H., Chahwan, R., Zhang, W., Smith, C., Pechuan-Jorge, X., Schaetzlein, S., Jin, B., Wang, Y., Bergman, A., et al. (2013) · Oncogene · doi:10.1038/onc.2013.365 · Cited by 54
PTIP promotes DNA double‐strand break repair through homologous recombination
Wang, X., Takenaka, K., & Takeda, S. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01379.x · Cited by 49
Measday, V., & Hieter, P. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)50971-x · Cited by 48
Park, J. M., Huang, S., Tougeron, D., & Sinicrope, F. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065369 · Cited by 45
Reinhardt, H. C., Cannell, I. G., Morandell, S., & Yaffe, M. B. (2011) · Cell Cycle · doi:10.4161/cc.10.1.14351 · Cited by 41
Self-citation
Cited by
Quadruplex Nucleic Acids as Novel Therapeutic Targets
Neidle, S. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01835 · Cited by 582
Liquid–liquid phase separation drives cellular function and dysfunction in cancer
Mehta, S., & Zhang, J. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00444-7 · Cited by 437
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
Kim, J., Mouw, K. W., Polak, P., Braunstein, L. Z., Kamburov, A., Tiao, G., Kwiatkowski, D. J., Rosenberg, J. E., Van Allen, E. M., D'Andrea, A. D., et al. (2016) · Nature Genetics · doi:10.1038/ng.3557 · Cited by 413
Gogola, E., Duarte, A. A., de Ruiter, J. R., Wiegant, W. W., Schmid, J. A., de Bruijn, R., James, D. I., Guerrero Llobet, S., Vis, D. J., Annunziato, S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.008 · Cited by 374
Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
Ahmed, S., Zhou, Z., Zhou, J., & Chen, S.-Q. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.03.008 · Cited by 371
Metadata
- Authors
- Dietlein, F., Thelen, L., & Reinhardt, H. C.
- Venue
- Trends in Genetics
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 30
- Issue
- 8
- Pages
- 326-339
- ISSN
- 0168-9525 (ISSN-L)
- OpenAlex
- W2094646262
- Cited by
- 280
- References
- 158
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.